We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Range Resources
RRC
$9.33B
| $1.99M | 0.01% |
75,222
-471,694
| -86% | -$11.9M |
|
502
Dover
DOV
$27.9B
| $1.99M | 0.01% |
13,081
-824
| -6% | -$121K |
|
|
MASI
503
DELISTED
Masimo
MASI
| $1.97M | 0.01% |
10,685
-5
| -0% | -$843 |
|
504
Inspire Medical Systems
INSP
$1.67B
| $1.97M | 0.01% |
8,416
+1,862
| +28% | +$471K |
|
505
Avantor
AVTR
$9.34B
| $1.93M | 0.01% |
91,238
+439
| +0.5% | +$10K |
|
506
Ally Financial
ALLY
$13.5B
| $1.92M | 0.01% |
+75,489
| New | +$2.16M |
|
507
Astronics
ATRO
$4.31B
| $1.92M | 0.01% |
+172,346
| New | +$1.93M |
|
508
Ennis
EBF
$557M
| $1.91M | 0.01% |
90,731
-1,859
| -2% | -$39.7K |
|
|
GMS
509
DELISTED
GMS Inc
GMS
| $1.91M | 0.01% |
32,995
+13,395
| +68% | +$759K |
|
510
Hackett Group
HCKT
$271M
| $1.89M | 0.01% |
102,538
-12,705
| -11% | -$256K |
|
511
PBF Energy
PBF
$8.57B
| $1.86M | 0.01% |
43,003
+36,894
| +604% | +$1.55M |
|
512
Haverty Furniture Companies
HVT
$446M
| $1.86M | 0.01% |
58,411
-5,506
| -9% | -$187K |
|
513
Innoviva
INVA
$1.51B
| $1.86M | 0.01% |
165,499
-18,509
| -10% | -$225K |
|
514
OneSpaWorld
OSW
$2.72B
| $1.86M | 0.01% |
+155,278
| New | +$1.69M |
|
515
REX American Resources
REX
$1.45B
| $1.85M | 0.01% |
129,762
-2,898
| -2% | -$45.8K |
|
516
Safe Bulkers
SB
$780M
| $1.85M | 0.01% |
502,178
-23,337
| -4% | -$78.4K |
|
|
CPRX
517
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.83M | 0.01% |
110,173
-17,462
| -14% | -$288K |
|
518
Wabtec
WAB
$49.8B
| $1.81M | 0.01% |
+17,918
| New | +$1.83M |
|
519
Timken Company
TKR
$9.08B
| $1.81M | 0.01% |
+22,145
| New | +$1.79M |
|
520
PC Connection
CNXN
$2.04B
| $1.81M | 0.01% |
40,164
-633
| -2% | -$28.9K |
|
521
Liberty Broadband Class A
LBRDA
$5.16B
| $1.81M | 0.01% |
21,986
-2,207
| -9% | -$190K |
|
522
OraSure Technologies
OSUR
$270M
| $1.79M | 0.01% |
+295,259
| New | +$1.67M |
|
523
Perrigo
PRGO
$1.75B
| $1.78M | 0.01% |
49,707
+698
| +1% | +$25.2K |
|
524
Movado Group
MOV
$815M
| $1.78M | 0.01% |
61,971
-4,855
| -7% | -$165K |
|
525
Build-A-Bear
BBW
$466M
| $1.78M | 0.01% |
76,470
-1,710
| -2% | -$39.7K |
|
Similar funds
FDCDDQ
TWC
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.